MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.48 B |
Market Cap[1] |
$ 105 B |
EBITDA (LTM) |
$ 4.18 B |
P/E (LTM) |
38.91 |
P/S (LTM) |
5.55 |
EPS (LTM) |
1.83 |
Boston Scientific is an international company that specializes in the development and manufacturing of medical devices and technologies for the treatment of various diseases. It was founded in 1979 in the United States and is now one of the largest medical device manufacturers in the world.
Boston Scientific offers a wide range of medical devices, including stents, cardiac pacemakers, defibrillators, electrodes, urological and gynecological devices, and much more. It also provides physician training, consultation, and patient support services.
The company has offices around the world and serves patients in over 100 countries. Its headquarters are located in Massachusetts, USA.
The goal of Boston Scientific is to help people live healthy lives by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
$ 2.21 | -0.43 % | $ 3.45 M | Nasdaq Capital Market | USA |
 |
Alphatec Holdings
ATEC
|
$ 12.93 | -0.92 % | $ 1.94 B | Nasdaq Global Select Market | USA |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 10.53 | 0.77 % | $ 1.42 B | Nasdaq Capital Market | USA |
 |
ClearPoint Neuro
CLPT
|
$ 9.69 | -13.17 % | $ 274 M | Nasdaq Capital Market | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Cytosorbents Corporation
CTSO
|
$ 0.66 | -2.96 % | $ 35.9 M | Nasdaq Capital Market | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 3.82 | -5.91 % | $ 142 M | Nasdaq Global Market |  France |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
Cognyte Software Ltd.
CGNT
|
$ 8.32 | -0.48 % | $ 597 M | Nasdaq Global Select Market,SPB |  Israel |
 |
Establishment Labs Holdings
ESTA
|
$ 65.54 | 0.81 % | $ 1.94 B | Nasdaq Capital Market |  Costa-rica |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
Butterfly Network
BFLY
|
$ 4.06 | -4.92 % | $ 859 M | NYSE | USA |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
CONMED Corporation
CNMD
|
$ 37.4 | 0.16 % | $ 1.16 B | NYSE,SPB | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
InMode Ltd.
INMD
|
$ 13.57 | -0.62 % | $ 877 M | Nasdaq Global Select Market,SPB | Israel |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
IRIDEX Corporation
IRIX
|
$ 1.33 | - | $ 21.5 M | Nasdaq Global Select Market | USA |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | Israel |
 |
OrthoPediatrics Corp.
KIDS
|
$ 16.8 | -2.38 % | $ 394 M | Nasdaq Global Select Market,SPB | USA |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
FONAR Corporation
FONR
|
$ 18.44 | -0.05 % | $ 121 M | Nasdaq Capital Market | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
Abbott Laboratories
ABT
|
$ 109.06 | -1.49 % | $ 190 B | NYSE,SPB | USA |
 |
Delcath Systems
DCTH
|
$ 9.49 | -2.57 % | $ 340 M | Nasdaq Capital Market | USA |
 |
Bio-Rad Laboratories
BIO
|
$ 269.13 | -0.13 % | $ 7.59 B | NYSE,SPB | USA |
 |
Helius Medical Technologies
HSDT
|
$ 2.07 | -4.61 % | $ 1.26 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 31.04 | -5.22 % | $ 1.43 B | Nasdaq Capital Market,SPB | USA |
 |
Align Technology
ALGN
|
$ 172.05 | -2.31 % | $ 12.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
$ 8.93 | -1.92 % | $ 688 M | Nasdaq Global Select Market,SPB | USA |
 |
Bruker Corporation
BRKR
|
$ 34.17 | 1.27 % | $ 5.09 K | Nasdaq Global Select Market,SPB | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
Apyx Medical Corporation
APYX
|
$ 3.74 | -0.13 % | $ 154 M | Nasdaq Global Select Market | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
Accuray Incorporated
ARAY
|
$ 0.39 | -0.46 % | $ 40.1 M | Nasdaq Global Select Market | USA |
 |
IRadimed Corporation
IRMD
|
$ 101.34 | -1.42 % | $ 1.29 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.